Filters

See more specimen types...

Other countries

See more countries

Results: 1 to 20 of 43 (representing 23 labs)

Tests names and labsConditionsGenes and analytesMethods

Parkinsons disease panel

Centogene AG - the Rare Disease Company
Germany
2830
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

AllNeuro panel

Centogene AG - the Rare Disease Company
Germany
7851205
  • C Sequence analysis of the entire coding region

PARK2 Parkinsonism

Centogene AG - the Rare Disease Company
Germany
21
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

PARK2

Neurogenetics DNA Diagnostic Laboratory Massachusetts General Hospital
United States
11
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Parkinson Disease Sequencing Panel

PreventionGenetics
United States
1716
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

PARK2. MLPA testing

Instituto de Medicina Genomica
Spain
11
  • D Deletion/duplication analysis

PARK2. Complete sequencing

Instituto de Medicina Genomica
Spain
11
  • C Sequence analysis of the entire coding region

Parkinson's Disease, Juvenile via the PARK2 Gene

PreventionGenetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

nucSEEK® Comprehensive Sequence Analysis Of The Nuclear Mitochondrial Exome

Courtagen Diagnostics Laboratory Courtagen Life Sciences
United States
560420
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Parkinson Disease Type 2, Sequencing PRKN (PARK2) Gene

Reference Laboratory Genetics
Spain
11
  • C Sequence analysis of the entire coding region

Dystonia Spotlight Panel

Courtagen Diagnostics Laboratory Courtagen Life Sciences
United States
2919
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

PARK2

Institute for Human Genetics University Clinic Freiburg
Germany
41
  • C Sequence analysis of the entire coding region

DYSTONIA

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
1513
  • C Sequence analysis of the entire coding region

PARKINSON DISEASE

GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases
Spain
1010
  • C Sequence analysis of the entire coding region

Parkinson Disease

Asper Biotech Asper Biotech Ltd.
Estonia
1716
  • C Sequence analysis of the entire coding region

Dystonia

Asper Biotech Asper Biotech Ltd.
Estonia
3738
  • C Sequence analysis of the entire coding region

PARK2(PARKIN) - Gene Sequencing & Del/Dup analysis

Genome Diagnostics VU University Medical Center
Netherlands
21
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • T Targeted variant analysis

NGS panel - Parkinson

Genome Diagnostics VU University Medical Center
Netherlands
2036
  • D Deletion/duplication analysis
  • S Mutation scanning of the entire coding region
  • T Targeted variant analysis

PARK2 Gene Sequencing

DDC Clinic Molecular Diagnostics Laboratory DDC Clinic, Center for Special Needs Children
United States
41
  • C Sequence analysis of the entire coding region

Parkinson disease type 2

Bioarray
Spain
11
  • D Deletion/duplication analysis

Results: 1 to 20 of 43

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center